High-risk prostate cancer-classification and therapy. Read more about High-risk prostate cancer-classification and therapy.
Prostate cancer: a new look at prostate cancer treatment complications. Read more about Prostate cancer: a new look at prostate cancer treatment complications.
Screening: biology dictates the fate of young women with breast cancer. Read more about Screening: biology dictates the fate of young women with breast cancer.
What are we learning from the cancer genome? Read more about What are we learning from the cancer genome?
Breast cancer screening: the questions answered. Read more about Breast cancer screening: the questions answered.
Urological cancer: For localized prostate cancer, does technology equal progress? Read more about Urological cancer: For localized prostate cancer, does technology equal progress?
The potential of exploiting DNA-repair defects for optimizing lung cancer treatment. Read more about The potential of exploiting DNA-repair defects for optimizing lung cancer treatment.
Challenges translating breast cancer gene signatures into the clinic. Read more about Challenges translating breast cancer gene signatures into the clinic.
Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. Read more about Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer.
Emerging therapeutic targets in endometrial cancer. Read more about Emerging therapeutic targets in endometrial cancer.
